𝔖 Bobbio Scriptorium
✦   LIBER   ✦

How to assess the pathogenicity of mutations in Charcot-Marie-Tooth disease and other diseases?

✍ Scribed by Andrzej Kochański

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
77 KB
Volume
47
Category
Article
ISSN
1234-1983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spectrum of mutations in Finnish patient
Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies
✍ Kaisa Silander; Päivi Meretoja; Vesa Juvonen; Jaakko Ignatius; Helena Pihko; Ari 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Our patient material included families and sporadic patients of Finnish origin with the diagnosis of Charcot-Marie-Tooth (CMT) disease types 1 and 2, Dejerine-Sottas syndrome (DSS), and hereditary neuropathy with liability to pressure palsies (HNPP). We screened for mutations in the peripheral myeli

Novel mutations in the Charcot-Marie-Too
Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1
✍ Kathrin Huehne; Vladimir Benes; Christian Thiel; Cornelia Kraus; Wolfram Kress; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. CMT type 1 is most frequently caused by a 1.4 Mb tandem duplication in chromosome 17p11.2 comprising the peripheral myelin protein 22 (PMP22) gene. Furthermore sequence variatio